MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

JOURNAL OF ZOO AND WILDLIFE MEDICINE, published by the American Association of Zoo Veterinarians, serves as a pivotal resource in the field of veterinary science, focusing specifically on the health and well-being of zoo and wildlife species. With an ISSN of 1042-7260 and an E-ISSN of 1937-2825, this journal is recognized for its significant contributions to animal science and has been categorized in the second quartile in both Animal Science and Zoology, as well as Veterinary disciplines, according to the latest rankings. It holds a respectable position within Scopus, being ranked #91 in General Veterinary and #290 in Animal Science and Zoology. While the journal operates on a subscription basis, its impactful research articles have been invaluable for clinicians, researchers, and students alike, providing crucial insights that advance wildlife conservation, veterinary practices, and animal health care from 1993 to the present. With a global reach and a targeted focus on both theoretical and practical applications, JOURNAL OF ZOO AND WILDLIFE MEDICINE is instrumental in fostering collaboration among professionals dedicated to the study and care of wild animal populations.

Welcome to the Journal of Taibah University Medical Sciences, a distinguished open-access publication dedicated to advancing knowledge in the field of medicine. Since its inception in 2006, and published by ELSEVIER, this journal has become a vital resource for researchers and healthcare professionals alike, reflecting a steadfast commitment to disseminating innovative research and high-quality medical studies. With an impressive impact factor and a Scopus ranking placing it in the top 25% of general medicine journals, this publication occupies a notable position in the academic landscape. The journal covers a wide array of topics within the medical sciences, from clinical research to public health initiatives. As a Q3 category journal in the 2023 rankings, it continues to attract submissions that contribute meaningfully to the diverse and evolving field of medicine, supporting an open-access model that ensures widespread accessibility to its invaluable content. Explore the Journal of Taibah University Medical Sciences to stay abreast of the latest scientific advancements and engage with fellow scholars across the globe.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.

Journal of Research in Medical Sciences is a leading open-access journal published by Wolters Kluwer Medknow Publications, dedicated to disseminating innovative research and advancements in the field of medicine. Established in 2005, the journal has earned a respectable Scopus rank of 205 out of 636 in General Medicine, placing it within the 67th percentile among its peers, indicative of its quality and influence in the field. With an Open Access policy adopted in 2015, the journal ensures that critical research findings are accessible to a global audience, thus fostering knowledge sharing and collaboration among researchers, medical professionals, and students. Operating out of Iran, the journal focuses on diverse aspects of medical science, offering a platform for emerging studies that span clinical practices to health-related outcomes. As a recognized publication in the Q3 quartile of medicine (miscellaneous) for 2023, the Journal of Research in Medical Sciences continues to play a pivotal role in promoting scholarly work and advancing medical knowledge, making it an essential resource for anyone invested in the evolution of healthcare and scientific inquiry.

The Ibnosina Journal of Medicine and Biomedical Sciences, published by THIEME MEDICAL PUBL INC, is a renowned platform dedicated to advancing research in the fields of medicine and biomedical sciences. With the ISSN 1947-489X, this journal provides a comprehensive outlet for high-quality original research, reviews, and clinical studies that aim to enhance our understanding of medical practices and biomedical innovations. The journal plays a vital role in disseminating knowledge that bridges the gap between scientific inquiry and practical application, making it essential for researchers, healthcare professionals, and students alike. By maintaining rigorous publication standards and fostering a collaborative academic environment, the Ibnosina Journal remains a cornerstone in supporting the growth and evolution of medical and biomedical sciences worldwide. While it does not currently offer Open Access options, the content continues to serve as a critical resource for enhancing scholarship in the discipline.

Biomedical and Biotechnology Research Journal is a pioneering, peer-reviewed Open Access platform dedicated to the advancement of knowledge in the fields of biomedical science and biotechnology. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS since 2017, this journal offers a vital resource for researchers, professionals, and students alike, encompassing a wide range of topics from molecular biology to innovative biotechnological applications. With an impact factor reflecting its commitment to quality research, it proudly ranks in the Q3 category for Biotechnology in 2023 and holds significant positions in Scopus ranks, emphasizing its relevance in the medical and biochemistry sectors. The journal is based in India, and with its open access model, it ensures that cutting-edge research is readily available to a global audience, fostering collaboration and innovation in the rapidly evolving world of biomedicine.